Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Critical RiskFDA Food
Medications & Supplements/Dietary Supplements

Garry N Sun USA Inc.: Mahayograj Guggulu Dietary Supplement Recalled for High Levels of Lead

Agency Publication Date: May 28, 2021
Share:
Sign in to monitor this recall

Summary

Garry N Sun USA Inc. has recalled 18 lbs. of Mahayograj Guggulu, a dietary supplement available in both vegetarian capsules and powder bags. Testing conducted by the State of Iowa found that the product contains extremely high levels of lead—measured at 12,200 mg/kg—which is far above safe consumption limits. This recall affects Mahayograj Guggulu sold in 120-count capsule bottles and 1/2 lb. powder bags distributed in several U.S. states, Canada, and Germany. Consumers should immediately stop using this supplement and return it to the place of purchase for a full refund.

Risk

Lead is a toxic substance that can cause serious health problems, including damage to the brain and nervous system, especially in children and pregnant women. Exposure to high levels of lead can lead to lead poisoning, which may result in kidney damage, high blood pressure, and cognitive impairments.

What You Should Do

  1. Check your packaging for Mahayograj Guggulu in 120 Vegetarian Capsules or 1/2 lb. bags of powder to see if it matches the recalled lot.
  2. Identify the affected product by looking for Lot number #11850 with a 'Use by' date of 12/31/2023 printed on the label.
  3. Immediately stop using the product if it matches the recalled lot and date information.
  4. Return the product to the place of purchase to receive a full refund or contact Garry N Sun USA Inc. at their Reno, Nevada location for further instructions.
  5. If you have consumed this supplement, contact your healthcare provider or pharmacist immediately to discuss potential lead exposure and health monitoring.
  6. For additional questions, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

💰Full Refund

Full refund for recalled supplement

How to: Return to the place of purchase for a full refund or contact the manufacturer for further instructions

Affected Products

Product: Mahayograj Guggulu (120 Vegetarian Capsules)
Item Code:
Recall #: F-0633-2021
Lot Numbers:
#11850 (Use by 12/31/2023)
Date Ranges: Use by 12/31/2023
Product: Mahayograj Guggulu (1/2 lb. bags of powder)
Item Code:
Recall #: F-0633-2021
Lot Numbers:
#11850 (Use by 12/31/2023)
Date Ranges: Use by 12/31/2023

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 87946
Status: Resolved
Manufacturer: Garry N Sun USA Inc.
Sold By: Garry N Sun USA Inc.
Manufactured In: United States
Units Affected: 18 lbs.
Distributed To: North Carolina, Arkansas, Hawaii, Idaho, New Mexico, Texas, Florida, Arizona, Washington, Michigan, California

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.